Takeda Pharmaceutical offered a premium of approximately $5.2 billion in cash to acquire Ariad Pharmaceuticals Inc. (Nasdaq: ARIA) sending the stock price soaring $10.01 to close at $23.75.
Takeda Pharmaceutical to buy Ariad Pharmaceuticals
January 09, 2017 at 17:46 PM EST
